HIV

HIV-positive patients have a higher risk of cardiovascular disease, along with higher rates of hypertension.

Top news of the day from across the healthcare landscape.

HIV-positive patients experience 4 times more chronic kidney disease cases than HIV-negative patients.

HIV-positive patients carry a heavy burden.

Pharmacists can manage HIV comorbid conditions, produce cost savings, reduce drug interactions, and expedite viral load suppression.

HIV-like virus eliminated from body with early administration of treatment.

With the advent of highly active antiretroviral therapy, HIV-infected patients are more likely to die of causes other than AIDS.

Linda Spooner, PharmD, RPh, BCPS, FASHP, professor of pharmacy practice at MCPHS University, discusses ways health-system pharmacists can assist HIV patients who have just been admitted.

Further research is needed for HIV to be treated by the CRISPR/Cas9 gene editing tool.

Protease inhibitors can lead to the development of cardiovascular disease, diabetes, and obesity in patients with HIV.

Pod-intravaginal rings offered complete protection from new SHIV infections in macaques.

Certain cancer cells evade the immune system through blocking NLRC5.

Several public health interventions could prevent HIV transmission among injection drug users.

Interdisciplinary teams are commonplace in HIV care, but the inclusion of a pharmacist on these care teams is relatively rare compared with other disease states.

Harnessing the immune system may lead to an effective HIV vaccine strategy.

Health-system pharmacists play a vital role in treating patients with HIV from the time they're admitted to their potential readmission, as well as through follow up after discharge.

In the lead up to National HIV Testing Day on June 27, 2016, Walgreens and Greater Than AIDS, a leading national public information response to the domestic HIV/AIDS epidemic, are teaming with health departments and local AIDS service organizations to offer free HIV testing and counseling about new prevention strategies.

Those who are HIV-negative but have risk factors for HIV can take pre-exposure prophylaxis with antiretroviral medications to protect themselves.

Greater education programming needed for patients at-risk for HIV infection.

A combination of chemotherapy and immunotherapy could be effective in treating ovarian cancer.

“HIV isn’t the end of the world. HIV is actually just the beginning.”

PEPFAR saw a 33% decrease in funding for HIV/AIDS services.

Accuracy improved in point-of-care urine testing for the screening of tuberculosis in HIV patients.

Researchers found that 80% of HIV-positive patients had increased aortic inflammation after starting antiretroviral therapy.

An increasing number of patients with HIV are 50 or older, which comes with new challenges for health care providers.

Acute infection screening program for HIV shows promise.

Study hopes to overcome significant challenges in producing an HIV vaccine.

Patients who enroll in studies, including those for pre-exposure prophylaxis, may share their medication with friends and family who have health concerns of their own or the same diagnoses.

Researchers evaluate mechanism that prevents immune system from attacking tumors in melanoma.

Immunotherapy combination increased T cell activity in the blood and the patient went into remission.